PASO vs JNJ: Which Stock is Better?
Side-by-side comparison of Patient Access Solutions Inc and Johnson & Johnson in 2026
PASO
Patient Access Solutions Inc
$0.00
JNJ
Johnson & Johnson
$234.18
Key Metrics Comparison
| Metric | PASO | JNJ | Winner |
|---|---|---|---|
| Market Cap | $0.25M | $564.35B | JNJ |
| P/E Ratio | N/A | 21.23 | JNJ |
| EPS (TTM) | $N/A | $11.03 | JNJ |
| Revenue Growth | -0.0% | 0.1% | JNJ |
| Gross Margin | 98.2% | 68.0% | PASO |
Analyze PASO
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PASO or JNJ a better investment?
Comparing PASO and JNJ: Patient Access Solutions Inc has a market cap of $0.25M while Johnson & Johnson has $564.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PASO and JNJ?
PASO (Patient Access Solutions Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PASO or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PASO or JNJ?
JNJ has higher revenue growth at 0.1% vs -0.0% for PASO.
Which company is more profitable: PASO or JNJ?
Patient Access Solutions Inc (PASO) has higher gross margins at 98.2% compared to 68.0% for JNJ.
Which is the larger company: PASO or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $564.35B compared to $0.25M for PASO.
Should I buy PASO or JNJ in 2026?
Both PASO and JNJ have investment merit. PASO trades at $0.00 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PASO and JNJ stock?
Key differences: Market Cap ($0.25M vs $564.35B), P/E Ratio (N/A vs 21.2x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (98.2% vs 68.0%).